Ligand validation:8DE2

NXL: (2S,5R)-1-formyl-5-[(sulfooxy)amino]piperidine-2-carboxamide

NXL is a Ligand Of Interest in 8DE2 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8DE2_NXL_D_301	82%	5%	0.107	0.961	2.48	2.89	3	8	1	0	100%	1
8DE2_NXL_B_301	74%	6%	0.111	0.94	2.46	2.7	3	7	0	0	100%	1
8DE2_NXL_C_301	72%	8%	0.142	0.966	2.5	2.1	4	8	2	0	100%	1
8DE2_NXL_A_301	70%	12%	0.122	0.94	2.5	1.59	5	5	3	0	100%	1
8DE0_NXL_B_301	94%	14%	0.075	0.973	2.08	1.79	5	2	0	0	100%	1
8DE1_NXL_A_301	88%	10%	0.083	0.959	2.46	1.83	4	6	1	0	100%	1
4HBU_NXL_A_301	100%	51%	0.04	0.993	0.56	1.31	-	1	0	0	100%	1
9BZQ_NXL_A_401	99%	38%	0.059	0.986	1.51	0.93	1	-	0	0	100%	1
4S2I_NXL_B_301	95%	12%	0.067	0.971	2.1	1.99	4	6	0	0	100%	1
8EK9_NXL_A_301	94%	10%	0.067	0.968	1.93	2.38	4	5	0	0	100%	1
5MOZ_NXL_A_701	94%	19%	0.067	0.967	1.87	1.56	4	5	0	0	100%	0.9412

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.